What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 40.2% in the afternoon session after the company ...

GoodRx (GDRX) shares soared nearly 50% on Monday after announcing a GLP-1 partnership with the Danish pharmaceutical behemoth ...

GoodRx Holdings, Inc.'s partnership with Novo Nordisk highlights its vital role in direct-to-consumer drug pricing. Click ...

GoodRx and Novo Nordisk launch a $499 monthly self-pay option for Ozempic and Wegovy, expanding access at 70,000 pharmacies across the U.S.

Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients ...

Detailed price information for Goodrx Holdings Inc Cl A (GDRX-Q) from The Globe and Mail including charting and trades.

Healthcare tech company GoodRx (NASDAQ:GDRX) missed Wall Street’s revenue expectations in Q2 CY2025 as sales only rose 1.2% ...

Healthcare tech company GoodRx (NASDAQ:GDRX) will be reporting earnings this Wednesday after the bell. Here’s what to expect.

GDRX currently has a forward P/E ratio of 15.42, while LHCG has a forward P/E of 35.36. We also note that GDRX has a PEG ratio of 0.94. This figure is similar to the commonly-used P/E ratio, with ...

GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of ...

GDRX's PEG compares to its industry's average PEG of 1.03. Over the last 12 months, GDRX's PEG has been as high as 2.37 and as low as 0.87, with a median of 1.18.

GoodRx Holdings, Inc. (GDRX) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.